By Gilang Cahya 
In a groundbreaking development that sheds light on a growing modern medical enigma, an international consortium of researchers, spearheaded by the University of California San Diego (UC San Diego), has pinpointed a microbial agent with a significant role in the alarming surge of early-onset colorectal cancer: a potent bacterial toxin known as colibactin. This discovery, published in the prestigious journal Nature on April 23, offers a compelling explanation for why colorectal cancer is increasingly diagnosed in individuals under the age of 50, a demographic previously considered at very low risk.
The research team, led by Professor Ludmil Alexandrov, a distinguished figure in bioengineering and cellular and molecular medicine at UC San Diego, has meticulously analyzed the genetic blueprints of hundreds of colorectal cancer tumors. Their findings reveal that colibactin, a DNA-damaging toxin produced by specific strains of Escherichia coli bacteria that commonly inhabit the human colon and rectum, leaves a distinct molecular signature on the DNA of colon cells. This signature, imprinted during early life, appears to significantly elevate the risk of developing colorectal cancer decades before the typical age of diagnosis.
A Genetic Fingerprint of Early-Life Exposure
The study’s methodology involved a comprehensive analysis of 981 colorectal cancer genomes, encompassing both early-onset (diagnosed before age 50) and late-onset cases. These genomes were sourced from patients across 11 countries, representing a diverse spectrum of colorectal cancer incidence rates. The researchers meticulously examined these genomes for specific patterns of DNA mutations that are characteristic of colibactin exposure.
The results were striking: these colibactin-induced mutation patterns were found to be 3.3 times more prevalent in early-onset colorectal cancer cases, particularly in adults under 40, when compared to individuals diagnosed with the disease after the age of 70. Furthermore, the prevalence of these mutational signatures correlated strongly with countries that exhibit a higher incidence of early-onset colorectal cancer, underscoring a potential geographical link and the influence of environmental or microbial factors.
"These mutation patterns are essentially a historical record etched into the genome," explained Professor Alexandrov, who also holds affiliations with the UC San Diego Moores Cancer Center and the Sanford Stem Cell Fitness and Space Medicine Center. "They unequivocally point to early-life exposure to colibactin as a primary driving force behind the development of early-onset colorectal cancer."
The Escalating Crisis of Early-Onset Colorectal Cancer
Colorectal cancer, once predominantly a disease affecting older adults, has witnessed a disturbing upward trajectory in younger populations. In at least 27 countries globally, incidence rates among individuals under 50 have roughly doubled each decade for the past 20 years. Projections suggest that if current trends persist, colorectal cancer is poised to become the leading cause of cancer-related mortality among young adults by 2030, a stark warning that necessitates urgent scientific inquiry and public health attention.
The reasons behind this alarming surge have, until now, remained largely elusive. Young adults diagnosed with colorectal cancer often lack a family history of the disease and present with few of the traditionally recognized risk factors such as obesity, a sedentary lifestyle, or a history of hypertension. This absence of clear etiological links has fueled speculation about the role of hitherto unrecognized environmental or microbial exposures – a hypothesis that this new research directly addresses.
A Serendipitous Discovery from Global Data
The genesis of this pivotal study was not initially focused on early-onset colorectal cancer. The original objective, as articulated by study co-first author Marcos Díaz-Gay, a former postdoctoral researcher in Alexandrov’s lab, was to explore global patterns of colorectal cancer to understand variations in incidence rates between countries. "Our original goal was to examine global patterns of colorectal cancer to understand why some countries have much higher rates than others," Díaz-Gay stated. "But as we dug into the data, one of the most interesting and striking findings was how frequently colibactin-related mutations appeared in the early-onset cases."
This unexpected observation pivoted the research’s focus, leading to a deep dive into the specific mutational signatures left by colibactin.
The Early Imprint of Colibactin
The team’s sophisticated molecular clock analysis of the mutational signatures provides crucial chronological insights. They demonstrated that colibactin-associated mutations emerge early in the tumor development process. This finding aligns with previous research suggesting that such DNA alterations can occur within the first decade of life.
Moreover, the study revealed that colibactin-related mutations constitute approximately 15% of what are known as "APC driver mutations." These are among the earliest and most critical genetic alterations that directly initiate and propel the development of cancer.
"If someone acquires one of these driver mutations by the time they’re 10 years old," Professor Alexandrov elaborated, "they could be decades ahead of schedule for developing colorectal cancer, getting it at age 40 instead of 60." This implies that colibactin-producing bacteria may silently colonize children’s colons, initiating subtle yet significant molecular changes in their DNA and laying the groundwork for colorectal cancer development long before any outward symptoms manifest.
While the evidence strongly supports this hypothesis, Professor Alexandrov emphasized the need for further research to definitively establish causality. "While our findings provide strong support for this hypothesis, further research is necessary to establish causality," he cautioned.
Building on a Foundation of Mutational Signature Analysis
This latest breakthrough is the culmination of years of dedicated research by Professor Alexandrov, Díaz-Gay, and their international collaborators. Their collective expertise lies in deciphering the intricate patterns of DNA mutations that arise from various environmental exposures, including ultraviolet radiation, bacterial toxins, and lifestyle factors such as smoking and alcohol consumption. Each of these factors leaves a unique genetic fingerprint – a distinct mutational signature – that can serve as a crucial clue in identifying the origins of specific cancers.
This research is part of the Cancer Grand Challenges initiative, specifically the Mutographs team, funded by Cancer Research UK. Through a sustained collaboration involving UC San Diego, the International Agency for Research on Cancer (France), and the Wellcome Sanger Institute (UK), the Mutographs team has previously elucidated the mutational processes underlying several other cancers, including esophageal, kidney, and head and neck cancers on a global scale. The current findings on colorectal cancer further expand this vital body of knowledge, enhancing the global understanding of cancer etiology through the powerful lens of mutational signature analysis.
By systematically cataloging these distinct mutational patterns across thousands of cancer genomes, the researchers are actively working to uncover new causes of cancer that may have previously eluded detection. "Not every environmental factor or behavior we study leaves a mark on our genome," Professor Alexandrov observed. "But we’ve found that colibactin is one of those that can. In this case, its genetic imprint appears to be strongly associated with colorectal cancers in young adults."
Future Directions and Unanswered Questions
The discovery of colibactin’s role in early-onset colorectal cancer opens a Pandora’s Box of new questions and potential avenues for intervention. Key among these are:
- Exposure Pathways: How are children becoming exposed to colibactin-producing bacteria? Understanding these pathways is crucial for developing targeted prevention strategies.
- Environmental Influences: Are specific environmental conditions, dietary habits, or lifestyle choices more conducive to the proliferation and toxin production of colibactin-producing E. coli strains?
- Detection and Mitigation: Can individuals determine if they carry these specific mutations? What interventions, such as probiotics, might safely help eliminate harmful bacterial strains from the gut?
The research team is actively pursuing several hypotheses to address these critical questions. They are further investigating the correlation between colibactin and the risk of early-onset colorectal cancer. Simultaneously, they are exploring the potential of probiotics as a therapeutic strategy for eradicating harmful bacterial strains. A significant area of development is the creation of early detection tests that analyze stool samples for the presence of colibactin-related mutations, offering a non-invasive screening method.
Regional Variations and the Global Perspective
Beyond the colibactin discovery, the Nature study also highlighted geographical variations in mutational signatures within colorectal cancer genomes. The researchers observed an increased prevalence of certain mutational signatures in colorectal cancers from specific countries, including Argentina, Brazil, Colombia, Russia, and Thailand. This finding suggests that localized environmental exposures may also play a significant role in contributing to cancer risk in different regions of the world.
"It’s possible that different countries have different unknown causes," commented Díaz-Gay, who is now leading a new phase of the study at the Spanish National Cancer Research Center (CNIO) in Madrid. "That could open up the potential for targeted, region-specific prevention strategies." This localized approach to cancer prevention, informed by specific mutational signatures, could revolutionize how we tackle the disease globally.
A Paradigm Shift in Cancer Etiology
The broader implication of this research is profound: it challenges the long-held notion that cancer is primarily a disease of accumulated damage over a lifetime. Instead, it strongly suggests that many cancers may originate from environmental or microbial exposures experienced in early life, potentially decades before diagnosis.
"This reshapes how we think about cancer," Professor Alexandrov concluded. "It might not be just about what happens in adulthood — cancer could potentially be influenced by events in early life, perhaps even the first few years. Sustained investment in this type of research will be critical in the global effort to prevent and treat cancer before it’s too late."
This paradigm shift underscores the critical importance of understanding the earliest molecular events that lead to cancer. By identifying and understanding the role of agents like colibactin, researchers are paving the way for novel preventive measures and early detection strategies, offering hope in the ongoing battle against cancer, particularly for younger generations who are increasingly bearing its burden. The continued exploration of mutational signatures promises to unlock further secrets of cancer’s origins, guiding us toward a future where cancer can be prevented, detected, and treated more effectively.
